Department of Nuclear Medicine & PET, Alfred Hospital, Melbourne Australia;
Monash University, Melbourne, Australia.
J Nucl Med. 2022 Dec;63(12):1899-1905. doi: 10.2967/jnumed.121.263688. Epub 2022 Apr 21.
Acute graft-versus-host disease of the gastrointestinal tract (acute GIT-GVHD) often complicates allogeneic hemopoietic stem cell transplantation (AHSCT). F-FDG PET/CT is known to detect active inflammation and may be a useful noninvasive test for acute GIT-GVHD. The objective of this study was to evaluate the diagnostic utility of F-FDG PET/CT to noninvasively assess patients with clinically suspected acute GIT-GVHD. Fifty-one AHSCT patients with clinically suspected acute GIT-GVHD prospectively underwent F-FDG PET/CT scanning followed by upper and lower GIT endoscopy within 7 d. Endoscopic biopsies of 4 upper GIT and 4 colonic segments were obtained for histology to compare with corresponding quantitative segmental F-FDG PET/CT SUV Receiver-operating-characteristic curve (ROC) analysis was performed to determine predictive capacity of F-FDG PET/CT SUV for acute GIT-GVHD. A separate qualitative visual F-FDG PET/CT analysis was also performed for comparison. Twenty-three of 51 (45.1%) patients had biopsy-confirmed acute GIT-GVHD, with 19 of 23 (82.6%) having upper GIT and 22 of 22 (100%) colonic involvement. One of 23 patients did not undergo a colonoscopy. GVHD involved the entire colon contiguously in 21 of 22 patients. For quantitative analysis, histology from 4 upper GIT and 4 colonic segments were compared with F-FDG PET/CT SUV Colonic segments positive for GVHD had a higher SUV (4.1 [95% CI, 3.6-4.5]) than did normal colonic segments (2.3 [1.9-2.7], = 0.006). No difference was demonstrated in upper GIT segments. Quantitative F-FDG PET/CT yielded a 69% sensitivity, 57% specificity, 73% negative predictive value, and 59% positive predictive value for the detection of GVHD compared with 70%, 76%, 76%, and 68%, respectively, for qualitative analysis. F-FDG PET is a useful noninvasive diagnostic test for acute GIT-GVHD, which when present always involves the colon and usually in its entirety, suggesting colonic biopsy obtained by sigmoidoscopy is adequate for histologic confirmation when acute GIT-GVHD is suspected. Of note, F-FDG PET cannot distinguish acute GIT-GVHD from non-GVHD inflammatory changes in the colon.
胃肠道(GIT)急性移植物抗宿主病(GVHD)常并发于异基因造血干细胞移植(AHSCT)。正电子发射断层扫描(PET)/CT 可用于检测活跃性炎症,对诊断 GIT-GVHD 具有一定价值。本研究旨在评估氟-18 氟代脱氧葡萄糖(18F-FDG)PET/CT 用于非侵入性评估疑似 GIT-GVHD 的患者的诊断效能。51 例疑似 AHSCT 后 GIT-GVHD 的患者行 18F-FDG PET/CT 扫描,7d 内行上、下 GIT 内镜检查。获取 4 个上 GIT 和 4 个结肠节段的内镜活检标本进行组织学检查,与相应的定量节段性 18F-FDG PET/CT SUV 值比较。通过受试者工作特征曲线(ROC)分析,评估 18F-FDG PET/CT SUV 值对 GIT-GVHD 的预测能力。同时进行独立的半定量视觉 18F-FDG PET/CT 分析进行比较。23/51(45.1%)例患者经活检证实为 GIT-GVHD,其中 19/23(82.6%)例为上 GIT,22/22(100%)例为结肠受累。1 例患者未行结肠镜检查。22 例患者中,21 例 GVHD 累及整个结肠连续部位。定量分析中,4 个上 GIT 和 4 个结肠节段的组织学与 18F-FDG PET/CT SUV 值进行比较。GVHD 阳性的结肠节段 SUV 值较高(4.1[95%CI,3.6-4.5]),而正常结肠节段 SUV 值较低(2.3[1.9-2.7], = 0.006)。上 GIT 节段无差异。与定性分析相比,定量 18F-FDG PET/CT 对 GVHD 的检测灵敏度为 69%、特异性为 57%、阴性预测值为 73%、阳性预测值为 59%;而定性分析的灵敏度为 70%、特异性为 76%、阴性预测值为 76%、阳性预测值为 68%。18F-FDG PET 是一种有用的 GIT-GVHD 非侵入性诊断检测方法,当存在 GVHD 时,其总是累及结肠,通常累及整个结肠,提示当怀疑 GIT-GVHD 时,通过乙状结肠镜获得的结肠活检可用于组织学确认。值得注意的是,18F-FDG PET 无法区分 GIT-GVHD 与结肠非 GVHD 炎症改变。